Crinetics Pharmaceuticals, Inc. Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five
Crinetics Pharmaceuticals, Inc. (CRNX) had Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five of $401.11 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost · last filed 2026-08-03
- 2026-06-30: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five $401.11M.
- 2026-03-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five $459.60M.
- 2025-12-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five $211.64M.
- 2025-09-30: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five $213.22M.
| Period end | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five as first filed |
|---|---|---|
| 2026-06-30 | $401.11M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $459.60M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $211.64M 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $213.22M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $293.31M 10-Q · filed 2025-08-07 | |
| 2024-12-31 | $467.06M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $447.56M 10-Q · filed 2025-05-08 | $117.98M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $116.24M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $45.90M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $467.06M 10-Q · filed 2025-05-08 | $88.65M 10-K · filed 2024-02-28 |
| 2023-09-30 | $120.63M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $491.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $27.06M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $59.41M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $88.69M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $114.41M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $86.14M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $102.29M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $18.30M 10-K · filed 2022-03-30 |